0 CHECKOUT

Analgesics in Ukraine

  • ID: 224169
  • April 2015
  • Region: Ukraine
  • 31 pages
  • Euromonitor International

In 2014 analgesics experienced very healthy 17% growth in current value terms, which translates into UAH1.3 billion spent on the products by Ukrainian retail consumers. Even though the trend is a continuation of the previous double-digit growth rates, in 2014 it came as a result of strong local currency devaluation and a 7% VAT introduction, which had a strong impact on unit price growth (eg, 11% in adult analgesics).

The Analgesics in Ukraine report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

ANALGESICS IN UKRAINE

April 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2009-2014
Table 2 Sales of Analgesics by Category: % Value Growth 2009-2014
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2009-2014
Table 4 NBO Company Shares of Analgesics: % Value 2010-2014
Table 5 LBN Brand Shares of Analgesics: % Value 2011-2014
Table 6 Forecast Sales of Analgesics by Category: Value 2014-2019
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2014-2019
Borschahivsky Khfz Nvts Zat in Consumer Health (ukraine)
Strategic Direction
Key Facts
Summary 1 Borschahivsky KhFZ NVTs ZAT: Key Facts
Summary 2 Borschahivsky KhFZ NVTs ZAT: Operational Indicators
Company Background
Production
Summary 3 Borschahivsky KhFZ NVTs ZAT: Production Statistics 2014
Competitive Positioning
Summary 4 Borschahivsky KhFZ NVTs ZAT: Competitive Position 2014
Darnitsa Ff Zat in Consumer Health (ukraine)
Strategic Direction
Key Facts
Summary 5 Darnitsa FF ZAT: Key Facts
Summary 6 Darnitsa FF ZAT: Operational Indicators
Company Background
Production
Summary 7 Darnitsa FF ZAT: Production Statistics 2013
Competitive Positioning
Summary 8 Darnitsa FF ZAT: Competitive Position 2014
GlaxoSmithKline Healthcare Ukraine Tov in Consumer Health (ukraine)
Strategic Direction
Key Facts
Summary 9 GlaxoSmithKline Healthcare Ukraine TOV: Key Facts
Summary 10 GlaxoSmithKline Healthcare Ukraine TOV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 GlaxoSmithKline Healthcare Ukraine TOV: Competitive Position 2014
Executive Summary
in 2014 Consumer Health Value Sales Grow Because of A Further Unit Price Rise
Consumer Health Products Consumption Is Adversely Affected by A Tense Situation in 2014
Ukrainian Companies Become More Competitive Due To Lower Prices Being More Appealing
Chemists/pharmacies Is the Typical Channel To Buy Consumer Health Products in Ukraine
Long-term Prospects Are Bright for Consumer Health in Ukraine
Key Trends and Developments
Ukrainian Consumers Face An Uneasy Period in the Country's History in 2014
Self-medication Remains Strong in Ukraine
Legislative Changes for Consumer Health Operators in Ukraine
Rural Vs Urban Key Trends and Developments
Trends
Competitive Landscape
Prospects
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 9 Life Expectancy at Birth 2009-2014
Market Data
Table 10 Sales of Consumer Health by Category: Value 2009-2014
Table 11 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 12 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 13 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 14 Distribution of Consumer Health by Format: % Value 2009-2014
Table 15 Distribution of Consumer Health by Format and Category: % Value 2014
Table 16 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 12 OTC: Switches 2012-2014
Definitions
Sources
Summary 13 Research Sources

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pfizer, Inc.
  • Boehringer Ingelheim GmbH